{"id":"a2e686f8-fb96-4c3b-95e2-6aa5d47ecc5a","slug":"intracranial-aneurysms-in-pediatric-population-treated-with-flow-diverters-a-single-center-experience","title":"Intracranial aneurysms in pediatric population treated with flow diverters: A single-center experience","authors":["Jorge Arturo Santos-Franco","Carlos Antonio Cruz-Argüelles","Fernando Agustin-Aguilar","Adrián Alejandro Abrego-Salinas","Martín Roberto Casas-Martínez","Jorge Luis Olivares-Peña"],"abstract":"Background: Pediatric intracranial aneurysms (PIAs) are uncommon. Flow diverters (FDs) have shown to be effective on treatment of selected aneurysms. Methods: We describe 10 cases of PIAs treated with FDs at one medical center in Mexico, from April 2015 to April 2020. Results: Out of 230 patients treated with FDs, 10 (4.3%) were pediatric. Average age was 9.4 years old (R: 6–15). Two patients (20%) had subarachnoid hemorrhage, 3 had epilepsy (30%), 3 (30%) had clinical signs of cranial nerve compression, and 4 (40%) had only headache. Two patients were in 1a grade of Hunt and Kosnik scale. Out of the nonruptured aneurysms, 7 (70%) were in 15 points of Glasgow Coma Scale and 1 patient (10%) was in 13 points. Treatment was performed without complications; nevertheless, appropriate distal deployment was not achieved in one case. At discharge, nine patients had 5 points of Glasgow Outcome Scale. All patients underwent computed tomography angiography or digital subtraction angiography at 1, 3, 6, and 12 months, 2 patients (20%) had a 2-year follow-up, and 3 patients (30%) had a 3-year follow-up. According to Kamran grading scale, 9 patients (90%) were classified as Grade 4 and 1 patient (10%) as Grade 3. Conclusion: Even though it is a small series, as this is an uncommon disease, we may suggest that FDs are useful to treat properly selected PIAs. Our study has consecutive imaging assessment at least a year of follow-up in which aneurysm stable occlusion was observed in 90% of patients.","thumbnailUrl":"https://sni-digital-videos.s3.amazonaws.com/articles/a2e686f8-fb96-4c3b-95e2-6aa5d47ecc5a/featured/hero-1781560749465.png","publishDate":"2022-11-11T00:00:00.000Z","doi":"10.25259/SNI_873_2022","categories":["Neurovascular","Original Article"],"fullTextUrl":"https://surgicalneurologyint.com/api/articles/a2e686f8-fb96-4c3b-95e2-6aa5d47ecc5a/pdf"}